EcoDrugPlus

Ensembl ID : ENSPMAG00000009494
Gene Symbol: -
Cross references: -
739 Possible Orthologues:

Ensembl ID : ENSPMAG00000009497
Gene Symbol: -
Cross references: -
280 Possible Orthologues:

Ensembl ID : ENSPMAG00000009498
Gene Symbol: -
Cross references: -
739 Possible Orthologues:

Ensembl ID : ENSPMAG00000009504
Gene Symbol: -
Cross references: -
739 Possible Orthologues:

Ensembl ID : ENSPMAG00000009563
Gene Symbol: -
Cross references: -
209 Possible Orthologues:

Ensembl ID : ENSPMAG00000009644
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSPMAG00000010369
Gene Symbol: -
Cross references: -
499 Possible Orthologues:

Ensembl ID : ENSPMAG00000000965
Gene Symbol: RPL19
1 Cross references
380 Possible Orthologues:

Ensembl ID : ENSPMAG00000001344
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSPMAG00000000606
Gene Symbol: -
Cross references: -
268 Possible Orthologues:

Ensembl ID : ENSPMAG00000002615
Gene Symbol: -
Cross references: -
454 Possible Orthologues:

Ensembl ID : ENSPMAG00000002862
Gene Symbol: -
Cross references: -
252 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).